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The hypothesis of the possible evolutionary role of tumors
suggests that hereditary tumors may supply evolving multicellu-
lar organisms with extra cell masses for the expression of newly
evolving genes (Kozlov, 2014). After expression of novel genes in
tumor cells, tumors may differentiate in new directions and give
rise to new cell types, tissues and organs.
In the presentation, the bulk of data supporting the positive
evolutionary role of tumors will be reviewed, obtained both in
the lab of the author and from the literature sources.
The following issues will be addressed: the widespread occur-
rence of tumors in multicellular organisms; features of tumors
that could be used in evolution; the relationship of tumors to
evo-devo; examples of recapitulation of some tumor features in
recently evolved organs; the types of tumors that might play the
role in evolution; examples of tumors that already have played
the role in evolution.
The discussion of experimental confirmation of nontrivial pre-
dictions of the hypothesis will include the analysis of evolution-
ary novelty of tumor-specifically expressed EST sequences;
ELFNI – AS1, a human gene with possible microRNA function
expressed predominantly in tumors and originated in primates;
PBOV1, a human gene of the recent de novo origin with predicted
highly tumor-specific expression profile; and the evolutionary
novelty of human cancer/testis antigen genes; the data obtained
on transgenic fish tumors regression model; and other data.
It can be concluded that expression of protogenes, evolution-
arily young and/or novel genes in tumors might be a new
biological phenomenon, a phenomenon of carcino-evo-devo
genes, predicted by the hypothesis of evolution by tumor
neofunctionalization.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.050
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Combined analyses of molecular data, such as DNA copy-
number alteration, mRNA and protein expression, point to biolog-
ical functions and molecular pathways being deregulated in mul-
tiple cancers. Genomic, metabolomic and clinical data from a
variety of solid cancers and model systems are emerging and
can be used to identify novel patient subgroups for tailored ther-
apy and monitoring. The first solid tumor to be profiled by expres-
sion arrays was carcinoma of the breast. The most reproducible
classification by mRNA expression is based on the biological enti-
ties referred to as the intrinsic subtypes; Luminal A, Luminal B,
Basal-like, HER2 enriched, and the Normal-like groups. In the past
decade a number of molecular studies to classify breast cancer
have added one or two additional molecular levels, most fre-
quently DNA copy number, and gene sequencing. However, few
of the studies have integrated more than two levels of informa-
tion from the same patients. We have in our lab collected several
layers of high throughput molecular data, TP53 mutation status
and high throughput paired end sequencing on a dataset of 110
patients. This dataset was clustered according to each molecular
level studied using an unbiased, unsupervised clustering, and
survival KM plots for each patient subgroup was created. While
some samples always cluster together at any molecular level,
others cluster in different groups according to each particular
molecular endpoint. Therefore, we used an integrated approach
to understand breast cancer heterogeneity by modeling mRNA,
copy number alterations, microRNAs, and methylation in a path-
way context utilizing the pathway recognition algorithm using
data integration on genomic models (PARADIGM). We show that
massive interleukin signaling profiles are observed in invasive
cancers and are absent or weakly expressed in healthy tissue
but already prominent in ductal carcinoma in situ, together with
ECM and cell-cell adhesion regulating pathways. A good correla-
tion was observed between methylation and mRNA expression
based classification (p = 2.29  106). Using PARADIGM based on
mRNA and miRNA expression, CNAs, and methylation five new
clusters with survival differences were revealed. Given the
increasing importance of immune constitution for the success
of chemotherapy and targeted treatment, this additional infor-
mation may prove useful in the clinic in the future.
http://dx.doi.org/10.1016/j.ejcsup.2015.08.051
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Background: The aim of this work was to assess the potential
of the optical methods for studying erythrocytes (Er) and blood
serum (BS) of patients with colorectal cancer (CC).
Methods: A total of 26 persons (52 + 8 years old) with CC (histo-
logically – adenocarcinoma) in the T1–2 stage (the 1st group con-
sisting of 10 patients) and in the terminal stage T3–4 (the 2nd
group involving 16 patients) were examined. The metastases (in
the liver area) were detected in 6 patients; the remaining patients
had no metastases. The degree of lymph node involvement in
most patients was not determined, the ten corresponding N1.
The control group consisted of 16 healthy people (50 + 6 years
old). Electric and viscoelastic Er parameters were investigated
by dielectrophoresis, their membrane structure – by TLC and
gas chromatography. The optical properties of BS were studied
by the methods of ellipsometry. The reaction of the monoclonal
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